Furthermore, treatment of BRAFMT colorectal cancer cells with vemurafenib significantly decreased BOLD-100-induced CYP1A1 mRNA levels [Fig. 6C (left); Supplementary Fig. S5D (top middle)]. Here, CYP1A1 is linked to colorectal cancer.